Astera Labs Inc. Common Stock
ALAB | NASDAQ
$240.95
-$17.75 (-6.86%)
Nov 2, 2026, 12:40 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Cash & Equivalents | 167.61M | 79.55M | 45.1M | 76.09M |
Short-Term Investments | 1.02B | 834.75M | 104.22M | 87.06M |
Long-Term Investments | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 77.76M | 5.88M | 2.9M | 2.2M |
Receivables | 83.2M | 38.81M | 8.34M | 10.72M |
Inventory | 58.98M | 43.22M | 24.1M | 28.87M |
Other Current Assets | 31.03M | 16.65M | 686K | 509K |
Total Current Assets | 1.36B | 1.01B | 185.81M | 206.01M |
Property-Plant & Equipment | 92.04M | 35.65M | 7.58M | 3.52M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 169.79M | 41.53M | 10.49M | 5.73M |
Total Assets | 1.53B | 1.05B | 196.29M | 211.73M |
Account Payables | 42.36M | 26.92M | 6.34M | 10.3M |
Deferred Revenue | n/a | 15M | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a |
Other Current Liabilities | 90.68M | 37.92M | 11.66M | 9.71M |
Total Current Liabilities | 133.04M | 86.54M | 35.08M | 40.09M |
Long-Term Debt | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 3.17M | 3.01M | 256.93M |
Total Long-Term Liabilities | 35.15M | 3.17M | 3.79M | 256.93M |
Total Liabilities | 168.19M | 89.71M | 38.87M | 297.02M |
Total Debt | 35.15M | 1.29M | 2.93M | 1.6M |
Book Value | 1.36B | 964.8M | 157.43M | -85.29M |
Book Value Per Share | 7.59 | 7.35 | 1.03 | -0.65 |
Common Stock | 17K | 16K | 4K | 4K |
Retained Earnings | 10.34M | -208.8M | -125.38M | -99.12M |
Comprehensive Income | 4.31M | 426K | 259K | -229K |
Shareholders Equity | 1.36B | 964.8M | 157.43M | -85.29M |
Total Investments | 1.02B | 834.75M | 104.22M | 87.06M |
Add to Watchlist
Select watchlists to add or remove ALAB